Alexza Reports Q4 EPS of $0.42

Alexza Pharmaceuticals, Inc. ALXA reported today financial results for the fiscal quarter and year ended December 31, 2010, and provided a general corporate update.

Alexza recorded net income of $25.4 million in the fourth quarter of 2010, while posting a net loss of $1.5 million for the year ended December 31, 2010, as reported in accordance with accounting principles generally accepted in the United States, compared to a net loss of $19.8 million and $56.1 million in the quarter and year ended December 31, 2009, respectively.

At December 31, 2010, Alexza had consolidated cash, cash equivalents and marketable securities of $41.4 million.

EPS $0.42